Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: Results from a randomized, blinded, controlled trial

Saad B. Omer, Khalequ Zaman, Eliza Roy, Shams E. Arifeen, Rubhana Raqib, Laila Noory, Katherine Seib, Robert F. Breiman, Mark C. Steinhoff

Research output: Contribution to journalArticlepeer-review

Abstract

A 2 × 2 factorial trial was performed to determine the efficacy of antennal influenza vaccination of mothers plus pneumococcal conjugate vaccination of their infants against respiratory illness during early infancy. The efficacy of trivalent inactivated influenza vaccine (TIV; delivered to mothers) plus 7-valent pneumococcal vaccine (PCV7; delivered to infants) was higher than the efficacy of TIV alone or PCV7 alone. During the period of the study in which influenza was circulating, the efficacy of TIV plus PCV7 was 72.4% (95% confidence interval, 30.2%-89.1%) against febrile respiratory illness and 66.4% (95% CI, 14.3%-86.9%) against medically attended acute respiratory illness. Clinical Trials registration NCT00142389.

Original languageEnglish (US)
Pages (from-to)1144-1147
Number of pages4
JournalJournal of Infectious Diseases
Volume207
Issue number7
DOIs
StatePublished - Apr 1 2013

Keywords

  • Influenza vaccine
  • influenza-like illness
  • pneumococcal conjugate vaccine
  • pregnancy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: Results from a randomized, blinded, controlled trial'. Together they form a unique fingerprint.

Cite this